Laboratory Question for the Week of October 5, 2020
MedLearn Publishing
October 3, 2020
May we bill separately for duplicative testing on the same bone marrow biopsy and bone marrow aspirate specimens?
May we bill separately for duplicative testing on the same bone marrow biopsy and bone marrow aspirate specimens?
What penalties is CMS imposing if a lab fails to comply with the new CLIA COVID requirements?
Can we perform repeat organ and disease-oriented panel procedures on a single day of service?
I’ve heard the government wants submission of COVID-19 lab data via electronic health records, do you have any tips for reporting this?
When performing chemistry testing, if a specific analyte is not listed in the lab section of the CPT® book, where should we be looking?
Can we bill for a P-Code when an irradiated unit is requested with the intent of transfusion, but the transfusion is not completed?
Is pool testing considered diagnostic for COVID-19?
What are some of the requirements for coding inclusion into the PLA section?
What guidance has the HHS suggested for COVID-19 laboratory data submission methods?
What code would I report for professional interpretation in molecular pathology?
Molecular diagnostic assays are one of the fastest growing segments for clinical diagnostics. Advancements in testing capabilities allows for rapid determination by simultaneously assessing multiple
When it comes to microbiology follow-up test coding, what can labs still report separate codes for?
Subscribe to receive our News, Insights, and Compliance Question of the Week articles delivered right to your inbox.
This Memorial Day, we honor those who gave all for our freedom. Take 20% off sitewide through May 29 with code MEMORIAL26Â at checkout
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24Â